Clostridium difficile erm(B)-containing elements and the burden on the in vitro fitness

References

1. Andersson D. I., Hughes D. 2010; Antibiotic resistance and its cost: is it possible to reverse resistance?. Nat Rev Microbiol 8:260–271[PubMed]
   [Google Scholar]
2. Barbut F., Mastrantonio P., Delmée M., Brazier J., Kuijper E., Poxton I.European Study Group on Clostridium difficile (ESGCD) 2007; Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 13:1048–1057 [View Article][PubMed]
   [Google Scholar]
3. Bidet P., Barbut F., Lalande V., Burghoffer B., Petit J. C. 1999; Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett 175:261–266 [View Article][PubMed]
   [Google Scholar]
4. Brouwer M. S. M., Warburton P. J., Roberts A. P., Mullany P., Allan E. 2011; Genetic organisation, mobility and predicted functions of genes on integrated, mobile genetic elements in sequenced strains of Clostridium difficile.. PLoS ONE 6:e23014 [View Article][PubMed]
   [Google Scholar]
5. Brouwer M. S. M., Roberts A. P., Mullany P., Allan E. 2012; In silico analysis of sequenced strains of Clostridium difficile reveals a related set of conjugative transposons carrying a variety of accessory genes. Mobile Genet Elements 2:8–12 [View Article][PubMed]
   [Google Scholar]
6. CLSI 2007; Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard M11-A7. Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
7. CLSI 2008; Performance Standards for Antimicrobial Susceptibility Testing; 18th Informational Supplement M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
8. Enne V. I., Delsol A. A., Davis G. R., Hayward S. L., Roe J. M., Bennett P. M. 2005; Assessment of the fitness impacts on Escherichia coli of acquisition of antibiotic resistance genes encoded by different types of genetic element. J Antimicrob Chemother 56:544–551 [View Article][PubMed]
   [Google Scholar]
9. Farrow K. A., Lyras D., Rood J. I. 2001; Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile.. Microbiology 147:2717–2728[PubMed]
   [Google Scholar]
10. Foucault M. L., Depardieu F., Courvalin P., Grillot-Courvalin C. 2010; Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci. Proc Natl Acad Sci U S A 107:16964–16969 [View Article][PubMed]
    [Google Scholar]
11. He M., Sebaihia M., Lawley T. D., Stabler R. A., Dawson L. F., Martin M. J., Holt K. E., Seth-Smith H. M. B., Quail M. A. other authors 2010; Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A 107:7527–7532 [View Article][PubMed]
    [Google Scholar]
12. He M., Miyajima F., Roberts P., Ellison L., Pickard D. J., Martin M. J., Connor T. R., Harris S. R., Fairley D. other authors 2013; Emergence and global spread of epidemic healthcare-associated Clostridium difficile.. Nat Genet 45:109–113 [View Article][PubMed]
    [Google Scholar]
13. Huang H., Weintraub A., Fang H., Nord C. E. 2009; Antimicrobial resistance in Clostridium difficile.. Int J Antimicrob Agents 34:516–522 [View Article][PubMed]
    [Google Scholar]
14. Jasni A. S., Mullany P., Hussain H., Roberts A. P. 2010; Demonstration of conjugative transposon (Tn5397)-mediated horizontal gene transfer between Clostridium difficile and Enterococcus faecalis.. Antimicrob Agents Chemother 54:4924–4926 [View Article][PubMed]
    [Google Scholar]
15. Liu S. L., Hessel A., Sanderson K. E. 1993; Genomic mapping with I-Ceu I, an intron-encoded endonuclease specific for genes for ribosomal RNA, in Salmonella spp., Escherichia coli, and other bacteria. Proc Natl Acad Sci U S A 90:6874–6878 [View Article][PubMed]
    [Google Scholar]
16. Schmidt C., Löffler B., Ackermann G. 2007; Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile. Diagn Microbiol Infect Dis 59:1–5 [View Article][PubMed]
    [Google Scholar]
17. Sebaihia M., Wren B. W., Mullany P., Fairweather N. F., Minton N., Stabler R., Thomson N. R., Roberts A. P., Cerdeño-Tárraga A. M. other authors 2006; The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 38:779–786 [View Article][PubMed]
    [Google Scholar]
18. Smith C. J., Markowitz S. M., Macrina F. L. 1981; Transferable tetracycline resistance in Clostridium difficile.. Antimicrob Agents Chemother 19:997–1003 [View Article][PubMed]
    [Google Scholar]
19. Spigaglia P., Mastrantonio P. 2002; Analysis of macrolide-lincosamide-streptogramin B (MLS(_B)) resistance determinant in strains of Clostridium difficile.. Microb Drug Resist 8:45–53 [View Article][PubMed]
    [Google Scholar]
20. Spigaglia P., Mastrantonio P. 2004; Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol 53:1129–1136 [View Article][PubMed]
    [Google Scholar]
21. Spigaglia P., Cardines R., Rossi S., Menozzi M. G., Mastrantonio P. 2001; Molecular typing and long-term comparison of Clostridium difficile strains by pulsed-field gel electrophoresis and PCR-ribotyping. J Med Microbiol 50:407–414[PubMed]
    [Google Scholar]
22. Spigaglia P., Carucci V., Barbanti F., Mastrantonio P. 2005; ErmB determinants and Tn916-Like elements in clinical isolates of Clostridium difficile. Antimicrob Agents Chemother 49:2550–2553 [View Article][PubMed]
    [Google Scholar]
23. Spigaglia P., Barbanti F., Mastrantonio P. 2011; Multidrug resistance in European Clostridium difficile clinical isolates. J Antimicrob Chemother 66:2227–2234 [View Article][PubMed]
    [Google Scholar]
24. Wüst J., Sullivan N. M., Hardegger U., Wilkins T. D. 1982; Investigation of an outbreak of antibiotic-associated colitis by various typing methods. J Clin Microbiol 16:1096–1101[PubMed]
    [Google Scholar]